期刊文献+

银屑病患者红细胞趋化因子受体与外周血淋巴细胞获得性免疫的相关性研究 被引量:1

Study for Correlation Lymphocyte Acquired Immunity and Erythrocyte Chemotactic Factor Receptor in Patient with Willan - Plumbe
下载PDF
导出
摘要 目的 探讨银屑病患者红细胞趋化因子受体 (ECKR)与细胞及体液免疫功能的相互关系。方法 用IL - 8作配体 ,分离一定量的红细胞与IL - 8结合 ,离心后取上清液用ELISA法检测IL - 8含量 ,反映红细胞上ECKR结合活性 ,并同时采用速率散射比浊法对血清中IgG、IgA、IgM含量进行测定 ,采用ELISA法测定血清可溶性白细胞介素 - 2受体 (sIL - 2R)水平。结果 银屑病患者ECKR结合活性明显降低 (P <0 .0 1) ,血清IgA含量明显增高 (P <0 .0 1) ,ECKR与sIL - 2R相关不显著 (r=0 .15 9,P >0 .0 5 ) ,而与IgA呈显著正相关 (r =0 .4 76 ,P <0 .0 5 )。结论 红细胞主要通过ECKR在银屑病发病过程中参与细胞因子的调控 。
出处 《深圳中西医结合杂志》 2003年第2期96-97,99,共3页 Shenzhen Journal of Integrated Traditional Chinese and Western Medicine
  • 相关文献

参考文献5

  • 1刘辉,顾军.银屑病与β趋化因子[J].国外医学(皮肤性病学分册),2002,28(2):85-87. 被引量:5
  • 2张乐之,郭峰,龚燕芳,王海滨.红细胞趋化因子受体测定方法的建立及临床初步应用[J].深圳中西医结合杂志,1999,9(5):10-13. 被引量:13
  • 3Neote K, Darbonne W Ogez J, et al. Idenlification of a proiiseuous inflammatory peptide receptor on the surface of red blood cells[J]. J Biol Chem, 1993, 268:12247
  • 4Chino H, Foster S, Thomas R, et al. A- melanocytestimulating hormone reduces endotoxin induced liver in fixation[J]. J Clin invest, 1997, 79:2038
  • 5Mackay CR. Chemokine receptors and T cell chemotoxis[J].Exp Med, 1996, 184:799

二级参考文献14

  • 1Hatano Y, Katagiri K, Takayasu S. Increased levels in vivo of mRNAs for IL-8 and macrophage inflammatory protein-1 alpha (MIP-1 alpha), but not of RANTES mRNA in peripheral blood mononuclear cells of patients with atopic dermatitis (AD). Clin Exp Immunol, 1999,117(2):237-243.
  • 2Maccbioni P, Boiardi L, Meliconi R, et al. Serum chemokines in patients with psoriasis arthritis treated with cyclosporin A. J Rheumatol, 1998,25(2):320-325.
  • 3Hocney B, Dieu-Nosjean MC, Wiesenborn A, et al. Up-regulation of macrophage inflammatory protein-3 alpha/CCL20 and CC chemokine receptor 6 in psoriasis. J Immunol, 2000,164(12):6621-6632.
  • 4Nakayama T, Fujisawa R, Yamada H, et al. Inducible expression of a CC chemokine liver- and activation-regulated chemokine (LARC)/macrophage inflammmatory protein (MIP)-3 alpha/CCL20 by epiderinal keratinocytes and its role in atopic dematitis. Int Immunol, 2001,13(1):95-103.
  • 5Dieu-Nosjean MC, Massacrier C, Homey B, et al. Macrophage inflammatory protein 3alpha is expressed at inflamed epithelial surfaces and is the most potent chemokine known in attracting Langerhas cell precursors. J Exp Med, 2000,192(5):705-718.
  • 6Raychaudhuri SP, Jiang WY, Farber EM, et al. Upregulation of RANTES in psoriatic keratinocytes: a possible pathogenic mechanism for psoriasis. Acta Derm Venereol. 1999,79(1):9-11.
  • 7Fukuoka M, Ogino Y, Sato H, et al. RANTES expression in psoriatic skin, and regulation of RANTES and IL-8 production in cultured epidermal keratinocytes ny active vitamin D3 (tacalcitol). Br J Dermatol, 1998, 138(1) :63-70.
  • 8Bornscheuer E, Zillikens D, Schroder JM, et al. Lack of expression of interleukin 8 and RANTES in autoimmune bullous skin diseases. Deramtology, 1999,198(2) : 118-121.
  • 9Raychaudhuri SK, Raychaudhuri SP, Father EM. Anti-chemotacitic activities of peptide-T: a possible mechamism of actions for its therapeutic effects on psoriasis. Int J Immunopharmacol, 1998,20(11) :661-667.
  • 10Gillitzer R, Ritter U, Spandau U, et al. Differential expression of GROalpha and IL-8 mRNA in psoriasis: a model, for neutrophil migratiol and accumulation in vivo.J Invest Dermatol, 1996 ,107(5):778-782.

共引文献15

同被引文献29

  • 1房婕,顾军,郭峰,花美仙,张乐之.红细胞趋化因子受体在寻常型银屑病患者外周血红细胞中的表达及其临床意义[J].深圳中西医结合杂志,2005,15(1):26-30. 被引量:2
  • 2Liu XH, Hadley TJ, Xu L, et al. Up-regulation of Duffy antigen receptor expression in children with renal disease[J]. Kidney Int, 1999,55(4) : 1491-1500.
  • 3Michon P ,Woolley I, Wood EM,et al. Duffy-null promoter heterozygosity reduces DARC expression and abrogates adhesion of the P. vivax ligand required for blood-stage infection[J] FEBS Lett, 2001,495-2 : 111- 114.
  • 4Tournamille C. Molecular basis and structure-activity relationships of the Duffy blood group antigens:chemokine and Plasmodium vivax receptors[J]. Transfus Clin Bio1,2000,7 (5) :497-509.
  • 5Tournamille C,Filipe A, Wasniowska K,et al. Strueture-function analysis of the extracellular domains of the Duffy antigen/receptor for chemokines : characterization of antibody and chemokine binding sites[J]. Br J Haematol. 2003,122(6) :1014-1023.
  • 6Tournamille C, Blancher A,Le Van Kim C, et al. Se-quence, evolution and ligand binding properties ofmammalian Duffy antigen/receptor for chemokines['J]. Immunogenetics. 2004,55 (10) : 682-694.
  • 7Lautenberger JA ,Stephens JC ,O'Brien SJ ,et al. Significant admixture linkage disequilibrium across 30 cM around the FY locus in African Americans [J]. Am J Hum Genet ,2000,66(3) : 969-978.
  • 8Woolley IJ,Hotmire KA,Sramkoski RM ,et al. Differential expression of the duffy antigen recptor for chemokines according to RBC age and FY genotype[J]. Transfusion, 2000,40 (8), 949-953.
  • 9Parasol N,Reid M,Rios M,et al. A novel mutation in the coding sequence of the FY * B allele of the Duffy chemokine receptor gene is associated with an altered erythrocyte phenotype [J]. Blood, 1998, 92 (7), 2237- 2243.
  • 10Yazdanbakhsh K, Rios M, Storry JR, et al. Molecular mechanisms that lead to reduced expression of duffy antigens[J]. Transfusion. 2000 ,40(3) :310-320.

引证文献1

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部